D
Biogen Inc. BIIB
$131.95 $3.953.09% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 2.65B 2.43B 2.45B 2.47B 2.46B
Total Other Revenue -- -- -- -- --
Total Revenue 2.65B 2.43B 2.45B 2.47B 2.46B
Cost of Revenue 552.50M 577.90M 583.50M 638.70M 501.90M
Gross Profit 2.09B 1.85B 1.87B 1.83B 1.96B
SG&A Expenses 581.30M 574.60M 678.70M 576.90M 550.30M
Depreciation & Amortization 127.40M 111.80M 91.00M 130.30M 86.90M
Other Operating Expenses 75.00M 58.10M 57.10M 69.30M 62.40M
Total Operating Expenses 1.73B 1.75B 1.93B 1.95B 1.66B
Operating Income 915.60M 681.90M 527.90M 511.40M 809.50M
Income Before Tax 744.00M 311.20M 291.50M 451.00M 698.70M
Income Tax Expenses 109.20M 70.70M 24.80M 62.50M 115.10M
Earnings from Continuing Operations 634.80M 240.50M 266.70M 388.50M 583.60M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 634.80M 240.50M 266.70M 388.50M 583.60M
EBIT 915.60M 681.90M 527.90M 511.40M 809.50M
EBITDA 1.11B 865.10M 711.90M 694.20M 968.40M
EPS Basic 4.33 1.65 1.83 2.67 4.01
Normalized Basic EPS 3.68 2.78 2.35 1.96 3.24
EPS Diluted 4.33 1.64 1.82 2.66 4.00
Normalized Diluted EPS 3.67 2.77 2.34 1.96 3.23
Average Basic Shares Outstanding 146.50M 146.10M 145.70M 145.70M 145.60M
Average Diluted Shares Outstanding 146.70M 146.60M 146.10M 146.10M 145.90M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --